DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis
DOI:
https://doi.org/10.2340/00015555-3794Keywords:
pharmacogenomic, CNV, psoriasis, anti-TNF drug, methylationAbstract
Biological drugs targeting tumour necrosis factor are effective for psoriasis. However, 30–50% of patients do not respond to these drugs and may even develop paradoxical psoriasiform reactions. This study searched for DNA copy number variations that could predict anti-tumour necrotic factor drug response or the appearance of anti-tumour necrotic factor induced psoriasiform reactions. Peripheral blood samples were collected from 70 patients with anti-tumour necrotic factor drug-treated moderate-to-severe plaque psoriasis. Samples were analysed with an Illumina 450K methylation microarray. Copy number variations were obtained from raw methylation data using conumee and Chip Analysis Methylation Pipeline (ChAMP) R packages. One copy number variation was found, harbouring one gene (CPM) that was significantly associated with adalimumab response (Bonferroni-adjusted p-value < 0.05). Moreover, one copy number variation was identified harbouring 3 genes (ARNT2, LOC101929586 and MIR5572) related to the development of paradoxical psoriasiform reactions. In conclusion, this study has identified DNA copy number variations that could be good candidate markers to predict response to adalimumab and the development of anti-tumour necrotic factor paradoxical psoriasiform reactions.
Downloads
References
Egeberg A. Psoriasis and comorbidities. Epidemiological studies. Dan Med J 2016; 63: B5201.
Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González-Parra E, et al. Position statement for the management of comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2018; 32: 2058-2073.
DOI: https://doi.org/10.1111/jdv.15177
Valsesia A, Macé A, Jacquemont S, Beckmann JS, Kutalik Z. The growing importance of CNVs: new insights for detection and clinical interpretation. Front Genet 2013; 30: 4.
DOI: https://doi.org/10.3389/fgene.2013.00092
Carpenter, D., Walker S, Prescott N, Schalkwijk J, Armour JAL. Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genomics 2011; 12: 418.
DOI: https://doi.org/10.1186/1471-2164-12-418
Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 2009; 10: 451-481.
DOI: https://doi.org/10.1146/annurev.genom.9.081307.164217
Pedrosa E, Carretero-Iglesia L, Boada A, Colobran R, Faner R, Pujol-Autonell I, et al. CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity. J Invest Dermatol 2011; 131: 1830-1837.
DOI: https://doi.org/10.1038/jid.2011.127
de Cid R, Riveira-Munoz E, Zeeuwen PLJM, Robarge J, Liao W, Dannhauser EN, et al. Deletion of the late cornified envelope (LCE) 3B and 3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41: 211-5.
DOI: https://doi.org/10.1038/ng.313
Hollox EJ, Huffmeier U, Zeeuwen PLJM, Palla R, Lascorz J, Rodijk-Olthuis D, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40: 23-25.
DOI: https://doi.org/10.1038/ng.2007.48
Prieto-Pérez R, Solano-López G, Cabaleiro T, Román M, Ochoa D, Talegón M, et al. New polymorphisms associated with response to anti-TNF drugs in patients with moderate-to-severe plaque psoriasis. Pharmacogenomics J 2018; 18: 70-75.
DOI: https://doi.org/10.1038/tpj.2016.64
Navarro R, Daudén E. Reacciones psoriasiformes paradójicas durante el tratamiento con terapia anti-factor de necrosis tumoral. Manejo clínico. Actas Dermo-Sifiliográficas 2014; 105: 752-761.
DOI: https://doi.org/10.1016/j.ad.2013.05.007
Cabaleiro T, Prieto-Pérez R, Navarro R, Solano G, Román M, Ochoa D, et al. Paradoxical psoriasiform reactions to anti-TNF? drugs are associated with genetic polymorphisms in patients with psoriasis. Pharmacogenomics J 2016; 16: 336-340.
DOI: https://doi.org/10.1038/tpj.2015.53
Ovejero-Benito MC, Muñoz-Aceituno E, Reolid A, Saiz-Rodríguez M, Abad-Santos F, Daudén E. Pharmacogenetics and pharmacogenomics in moderate-to-severe psoriasis. Am J Clin Dermatol 2018; 19: 209-222.
DOI: https://doi.org/10.1007/s40257-017-0322-9
Daudén E, Puig L, Ferrándiz C, Sánchez-Carazo JL, Hernanz-Hermosa JM, the Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol 2016; 30: 1-18.
DOI: https://doi.org/10.1111/jdv.13542
Ovejero-Benito MC, Cabaleiro T, Sanz-García A, Llamas-Velasco M, Saiz-Rodríguez M, Prieto-Pérez R, et al. Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis. Br J Dermatol 2018; 178: 798-800.
DOI: https://doi.org/10.1111/bjd.15504
Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinforma Oxf Engl 2017; 33: 3982-3984.
DOI: https://doi.org/10.1093/bioinformatics/btx513
Nishikawa R, Nagai H, Bito T, Ikeda T, Horikawa T, Adachi A, et al. Genetic prediction of the effectiveness of biologics for psoriasis treatment. J Dermatol 2016; 43: 1273-1277.
DOI: https://doi.org/10.1111/1346-8138.13412
Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, et al. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med Off J Am Coll Med Genet 2018; 20: 622-629.
DOI: https://doi.org/10.1038/gim.2017.156
Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest 2006; 116: 2084-2087.
DOI: https://doi.org/10.1172/JCI29441
Swindell WR, Johnston A, Xing X, Voorhees JJ, Elder JT, Gudjonsson JE. Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation. Spencer J, editor. PLoS ONE 2013; 8: e79253.
DOI: https://doi.org/10.1371/journal.pone.0079253
Dijkstra JM, Alexander DB. The "NF-?B interacting long noncoding RNA" (NKILA) transcript is antisense to cancer-associated gene PMEPA1. F1000Research 2015; 4: 96.
DOI: https://doi.org/10.12688/f1000research.6400.1
Ovejero-Benito MC, Prieto-Pérez R, Llamas-Velasco M, Muñoz-Aceituno E, Reolid A, Saiz-Rodríguez M, et al. Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis. Pharmacogenomics 2018; 19: 7-16.
DOI: https://doi.org/10.2217/pgs-2017-0143
He Y, Hoskins JM, McLeod HL. Copy number variants in pharmacogenetic genes. Trends Mol Med 2011; 17: 244-251.
DOI: https://doi.org/10.1016/j.molmed.2011.01.007
Goiriz R, Daudén E, Pérez-Gala S, Guhl G, García-Díez A. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol 2007; 32: 176-179.
DOI: https://doi.org/10.1111/j.1365-2230.2006.02315.x
Weir L, Robertson D, Leigh IM, Vass JK, Panteleyev AA. Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim Biophys Acta 2011; 1813: 60-72.
DOI: https://doi.org/10.1016/j.bbamcr.2010.11.014
Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 2009; 90: 232-248.
DOI: https://doi.org/10.1111/j.1365-2613.2009.00669.x
Feber A, Guilhamon P, Lechner M, Fenton T, Wilson GA, Thirlwell C, et al. Using high-density DNA methylation arrays to profile copy number alterations. Genome Biol 2014; 15: R30.
DOI: https://doi.org/10.1186/gb-2014-15-2-r30
Feng G, Hobbs J, Lu X, Yu Y, Du P, Kibbe WA, et al. A statistical method to estimate DNA copy number from Illumina high-density methylation arrays. Syst Biomed 2013; 1: 94-98.
DOI: https://doi.org/10.4161/sysb.25896
Korshunov A, Schrimpf D, Ryzhova M, Sturm D, Chavez L, Hovestadt V, et al. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers. Acta Neuropathol (Berl) 2017; 134: 507-516.
DOI: https://doi.org/10.1007/s00401-017-1710-1
Knoll M, Debus J, Abdollahi A. cnAnalysis450k: an R package for comparative analysis of 450k/EPIC Illumina methylation array derived copy number data. Bioinformatics 2017; 33: 2266-2272.
DOI: https://doi.org/10.1093/bioinformatics/btx156
Cho S, Kim HS, Zeiger MA, Umbricht CB, Cope LM. Measuring DNA Copy Number Variation Using High-Density Methylation Microarrays. J Comput Biol 2019; 26: 295-294.
DOI: https://doi.org/10.1089/cmb.2018.0143
Nordlund J, Bäcklin CL, Lönnerholm G, Syvänen AC, Almlöf JC. CopyNumber450k Cancer: baseline correction for accurate copy number calling from the 450k methylation array. Bioinformatics 2016; 32: 1080-1082.
DOI: https://doi.org/10.1093/bioinformatics/btv652
Min JL, Hemani G, Davey Smith G, Relton C, Suderman M. Meffil: efficient normalization and analysis of very large DNA methylation datasets. Bioinformatics 2018; 34: 3983-3989.
DOI: https://doi.org/10.1093/bioinformatics/bty476
Müller F, Scherer M, Assenov Y, Lutsik P, Walter J, Lengauer T, Bock C. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol 2019; 20: 55.
DOI: https://doi.org/10.1186/s13059-019-1664-9
Gu X, Nylander E, Coates PJ, Fahraeus R, Nylander K. Correlation between Reversal of DNA methylation and clinical symptoms in psoriatic epidermis following narrow-band UVB phototherapy. J Invest Dermatol 2015; 135: 2077-2083.
DOI: https://doi.org/10.1038/jid.2015.128
Chandra A, Senapati S, Roy S, Chatterjee G, Chatterjee R. Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis. Clin Epigenetics 2018; 10: 108.
DOI: https://doi.org/10.1186/s13148-018-0541-9
Haraksingh RR, Abyzov A, Urban AE. Comprehensive performance comparison of high-resolution array platforms for genome-wide copy number variation (CNV) analysis in humans. BMC Genomics 2017; 18: 321.
Additional Files
Published
How to Cite
License
Copyright (c) 2021 Ancor Sanz-Garcia, Alejandra Reolid, Laura H. Fisas, Ester Muñoz-Aceituno, Mar Llamas-Velasco, Antonio Sahuquillo-Torralba, Rafael Botella-Estrada, Jorge García-Martínez, Raquel Navarro, Esteban Daudén, Francisco Abad-Santos, Maria C. Ovejero-Benito
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
